Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics
  • Log in
Advertisement

Main menu

  • Home
  • About Us
    • AACR Journals
    • Subscriptions
    • Permissions & Reprints
    • Advertising
  • Article Collections
    • Focus Sections
    • Journal Collections
    • Topical Collections
    • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
  • Alerts
    • Table of Contents
    • Editors' Picks
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Log in

Search

  • Advanced search
American Association for Cancer Research

American Association for Cancer Research

Advanced Search

  • Home
  • About Us
    • AACR Journals
    • Subscriptions
    • Permissions & Reprints
    • Advertising
  • Article Collections
    • Focus Sections
    • Journal Collections
    • Topical Collections
    • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
  • Alerts
    • Table of Contents
    • Editors' Picks
  • Visit AACR on Facebook
  • Follow AACR on Twitter
  • Visit AACR on LinkedIn
  • Visit AACR on YouTube

In the Spotlight


The AACR Annual Meeting is here! Visit Publications booth #1431 for Meet-the- Editor sessions today, featuring: Dr. Timothy R. Rebbeck, Cancer Epidemiology, Biomarkers and Prevention, at 10 AM, Drs. Lewis C. Cantley, and José Baselga, Cancer Discovery, at 11 AM, and Dr. Karen E. Knudsen, Molecular Cancer Research, at 2PM. Pick up the latest journal issues, special collections and "The Best of the AACR Journals" collection.


The Best of the AACR Journals collection highlights the most-cited articles published in 2016 across the AACR journals. Congratulations to the authors of these outstanding articles for their tireless efforts and contributions to the cancer research field.


New! In preparation for the AACR Annual Meeting 2018, read recently published, impactful, AACR journal articles related to the Annual Meeting sessions.


Read 'BEThinking Independent Functions for BET Proteins in EMT,' the latest Rapid Impact article from MCR, in which Andrieu and Denis uncover distinct and opposing functions for bromodomain and extra-terminal (BET) domain proteins. BET proteins are known to be involved in transcriptional activity and are important regulators of cancer progression. The current data demonstrate, through manipulation of individual BET proteins, that independent transcriptional programs are at play in the context of epithelial-to-mesenchymal (EMT) transition in breast cancer. Thus, suggesting that the status of individual BET protein should be considered, especially under conditions that use pan-BET domain inhibition strategies. For more information about the Rapid Impact article visit the MCR Rapid Impact Archive.

 

Learn More About the AACR's Journals:

Cancer Discovery
publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies. The journal also publishes News and Research Watch sections.
Cancer Epidemiology, Biomarkers & Prevention
publishes articles featuring population-based research on cancer etiology, prevention, surveillance, survivorship, and cancer health disparities-- with a particular focus on articles with a transdisciplinary approach.
Cancer Immunology Research
publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials.
Cancer Prevention Research
publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences." title="Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences.
Cancer Research
publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the journal is captured in its primary subsections: Genome and Epigenome, Metabolism and Chemical Biology, Molecular Cell Biology, Tumor Biology and Immunology, Translational Science, Convergence and Technologies, and Population and Prevention Science.
Clinical Cancer Research
publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; immunotherapy; gene therapy; diagnostic biomarkers; innovative imaging, and clinical genetics.
Molecular Cancer Research
publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and senescence; cell death and survival; chromatin, gene and RNA regulation; DNA damage and repair; genomics; oncogenes and tumor suppressors; and signal transduction.
Molecular Cancer Therapeutics
publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanism of drug resistance, biomarkers of drug response, novel models and technologies, and occasional drug toxicity mechanisms.
 
Advertisement
Back to top
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   YouTube   RSS

Article Collections

  • Focus Selections
  • Topical Collections
  • "Best of" Collection

Info for:

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

AACR Journals

  • About AACR Journals
  • 3rd Party Permissions & Reprints

AACR logo

Copyright © 2018 by the American Association for Cancer Research.